Property:Gender specifications
This is a property of type Text.
D
Gender per arm in n(%):
Enzyme-arm: male= 33 (91.7%); female= 3 (8.3%)
Placebo-arm: male= 24 (72.7%); female= 9 (36.4%) +
E
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
Of the 17 analysed patients: 15 male, 2 female +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
Male n(%) per arm:
Green tea arm: 9 (42.9), placebo arm: 14 (66.7)
Female n(%) per arm:
Green tea arm: 12 (57.1), placebo arm: 7 (33.3) +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
24 male, 6 women +
F
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
28 % female +
Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? +
77.8% female +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Male, n(%) per arm:
Sativex = 106 (53.0)
Placebo = 97 (48.7)
Female, n(%) per arm:
Sativex = 194 (47.0)
Placebo = 102 (51.3) +
Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Part A
Female = 176 (43.6%)
Part B
Sativex = 40 (38.8%) female
Placebo = 48 (46.6%) female +
Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial +
11.1% female +
Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial +
n=120 (49%) male and n=124 (51%) female +
Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2) +
Male, n (%): 57 (100) +
G
Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation +
53% female +
Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial +
Female intervention arm: 13.2%, placebo arm: 21.3% +
Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer +
Intervention arm: n=15 male and n=1 female
Control arm: n=24 male, n=0 female +
Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial +
Female : 61 (78%)
Male: 17 (22%) +
Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers +
Gender per arm:
Enzyme-arm: male= 34(64%); female= 16(36%)
Control-arm: male= 35(74%); female= 12(26%) +
H
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
Intervention arm: 16 (53.3%) male
Control arm: 14 (46.7%) male +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
70% men +
Showing 1 related entity.